Document is current

Article History

Received: 2 April 2019

Accepted: 22 October 2019

First Online: 26 November 2019

Change Date: 10 May 2024

Change Type: Clarification

Change Details: Editor’s Note: Readers are alerted that concerns have been raised regarding the reliability of some of the data presented in this article. Further editorial action will be taken if appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.

Competing interests

: B.G.N. is a co-founder, holds equity in, and received consulting fees from Navire Pharmaceuticals and Northern Biologics, Inc. He also is a member of the Scientific Advisory Board, and receives consulting fees and equity from Avrinas, Inc, and is an expert witness for the Johnson and Johnson ovarian cancer talc litigation. His spouse has equity in Mirati Therapuetics, Amgen, Inc., Arvinas, Inc. and Array Biopharma. The other authors declare no competing interests.